Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Countries and organisations
Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.
Free access · No subscription for research tools or data exports
Explore registry geography and organisations
6 trials match this view; 10 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 171 across 6 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Countries with reported trial locations
Sponsors recorded in this index
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsAnorexia Nervosa | Region Skane PHASE2 | Recruiting Registry updated 2026-08-14 | 40 ESTIMATED | 2026-07-20 2027-10-01 2027-10-01 | |
| Study of Psilocybin for Anorexia in Young AdultsAnorexia Nervosa | Marissa Raymond-Flesch, MD, MPH PHASE2 | Recruiting Registry updated 2026-03-03 | 40 ESTIMATED | 2024-11-18 2029-11 2029-11 | |
| Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept StudyAnorexia Nervosa | COMPASS Pathways PHASE2 | Completed Registry updated 2024-12-04 | 32 ACTUAL | 2022-10-12 2024-11-18 2024-11-18 | |
| Psilocybin as a Treatment for Anorexia Nervosa: A Pilot StudyAnorexia Nervosa | Imperial College London PHASE1, PHASE2 | Completed Registry updated 2024-06-17 | 21 ACTUAL | 2021-05-28 2023-12-11 2024-06-12 | |
| Effects of Psilocybin in Anorexia NervosaAnorexia Nervosa | Johns Hopkins University PHASE1 | Completed Registry updated 2023-05-06 | 22 ACTUAL | 2019-08-26 2022-01-05 2023-04-20 | |
| Evaluation of Psilocybin in Anorexia Nervosa: Safety and EfficacyAnorexia Nervosa | University of California, San Diego PHASE2 | Completed Registry updated 2022-07-25 | 16 ACTUAL | 2021-05-01 2022-03-10 2022-06-10 |
Reported research facilities
Psykiatrikliniken, Baravägen 1Lund, Sweden
University of California, San FranciscoSan Francisco, California, United States
Altman Clinical and Translational Research InstituteSan Diego, California, United States
Sheppard Pratt Health SystemBaltimore, Maryland, United States
Dell Medical SchoolAustin, Texas, United States
Tallaght University HospitalDublin, Ireland
Kings College London, Institute of Psychiatry, Psychology and NeurologyLondon, United Kingdom
Imperial College Hammersmith campusLondon, United Kingdom
Behavioral Pharmacology Research UnitBaltimore, Maryland, United States
Altman Clinical and Translational Research InstituteLa Jolla, California, United States
This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.